Jiangxi Synergy Pharmaceutical Receives China Approval for Type 2 Diabetes Tablets
Idag, 13:14
Idag, 13:14
07:14 AM EDT, 05/19/2026 (MT Newswires) -- China's drug regulator approved Jiangxi Synergy Pharmaceutical's (SHE:300636) empagliflozin tablets, according to an after-hours filing on Monday with the Shenzhen bourse.
Shares rose 1% during the close of trading Tuesday.
The drug is indicated for type 2 diabetes patients.
Idag, 13:14
07:14 AM EDT, 05/19/2026 (MT Newswires) -- China's drug regulator approved Jiangxi Synergy Pharmaceutical's (SHE:300636) empagliflozin tablets, according to an after-hours filing on Monday with the Shenzhen bourse.
Shares rose 1% during the close of trading Tuesday.
The drug is indicated for type 2 diabetes patients.
Nibe
Evolution
Nibe
Evolution
1 DAG %
Senast
OMX Stockholm 30
0,84%
(14:56)
Intrum
Idag, 10:19
Intrums aktie klättrar efter köpråd
OMX Stockholm 30
1 DAG %
Senast
3 081,57